Treatment of Neurocardiogenic Syncope

Treatment of Neurocardiogenic Syncope

To the Editor: Sra et al. (April 15 issue) 1 found that in patients with neurocardiogenic syncope associated with bradycardia or asystole, drug therapy is often effective in preventing syncope, whereas artificial pacing is not. This study raises important questions about the methods used to diagnose...

Full description

Saved in:
Bibliographic Details
Published in:The New England journal of medicine Vol. 329; no. 13; pp. 969 - 970
Main Authors: van Lieshout, J J, Jellema, W T, Wieling, W
Format: Journal Article
Language:English
Published: United States Massachusetts Medical Society 23-09-1993
Subjects:
Bradycardia - complications
Heart Arrest - complications
Humans
Posture
Syncope - etiology
Syncope - therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To the Editor: Sra et al. (April 15 issue) 1 found that in patients with neurocardiogenic syncope associated with bradycardia or asystole, drug therapy is often effective in preventing syncope, whereas artificial pacing is not. This study raises important questions about the methods used to diagnose vasovagal responses and evaluate treatment. The reported mean time of seven minutes from the onset of tilt testing to syncope is extremely short. We suggest that the heavily invasive instrumentation used in the study contributed to both the incidence and the early onset of syncope. Intravascular instrumentation has been shown to raise the incidence of . . .
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJM199309233291318